Table 1 Host factors and urine LAM Status of 199 study participants
Host Factors | Total n = 199 | LAM Negative n = 167 (83.9%) | LAM Positive* n = 32 (16.1%) | p-value** |
|---|---|---|---|---|
Median age years [IQR] | 34 [28-43] | 35 [30-40] | 34 [28-44] | 0.929†|
Gender |  |  |  | 0.904††|
Male | 110 | 92 (55.1) | 18 (56.3) | Â |
Female | 89 | 75 (44.9) | 14 (43.8) | Â |
Patient TB category |  |  |  | 0.968††|
New TB case | 125 | 105 (62.9) | 20 (62.5) | Â |
Re-treatment TB case | 74 | 62 37.1) | 12 (37.5) | Â |
Site of disease |  |  |  | 0.613‡ |
Pulmonary | 168 | 141 (84.4) | 27 (84.4) | Â |
Extra-Pulmonary | 18 | 16 (9.6) | 2 (6.3) | Â |
Pulmonary and Extra-Pulmonary | 13 | 10 (6) | 3 (9.4) | Â |
Smear or culture positive |  |  |  | < 0.001‡ |
Positive | 119 | 90 (53.9) | 29 (90.6) | Â |
Negative | 79 | 76 (45.5) | 3 (9.4) | Â |
Not done | 1 | 1 (0.6) | 0 (0) | Â |
HIV status |  |  |  | 0.002‡ |
Positive | 146 | 117 (70.1) | 29 (90.6) | Â |
Negative | 52 | 50 (29.9) | 2 (6.3) | Â |
Unknown | 1 | 0 (0) | 1 (3.1) | Â |
Median CD4 cells/μL. [IQR] a | 132.5 [70-283] | 156 [80-309] | 95 [42-134] | 0.006†|
< 50 | 26 | 17 (14.5) | 9 (31) | Â |
50-99 | 28 | 22 (18.8) | 6 (20.7) | Â |
100-199 | 39 | 31 (26.5) | 8 (27.6) | Â |
≥ 200 | 53 | 47 (40.2) | 6 (20.7) |  |
ART at start of TB treatment a |  |  |  | 0.078††|
Yes | 33 | 30 (25.6) | 3 (10.3) | Â |
No | 113 | 87 (74.4) | 26 (89.7) | Â |